Circulating Levels of the Soluble Receptor for AGE (sRAGE) during Escalating Oral Glucose Dosages and Corresponding Isoglycaemic i.v. Glucose Infusions in Individuals with and without Type 2 Diabetes.

Abstract

Postprandial glucose excursions are postulated to increase the risk for diabetes complications via the production of advanced glycation end products (AGEs). The soluble receptor of AGEs (sRAGE) likely acts as a decoy receptor, mopping up AGEs, diminishing their capacity for pro-inflammatory and pro-apoptotic signaling. Recent evidence suggests that AGEs and soluble receptor for AGEs (sRAGE) may be altered under postprandial and fasting conditions. Here, we investigated the effects of increasing oral glucose loads during oral glucose tolerance tests (OGTT) and matched isoglycaemic intravenous (i.v.) glucose infusions (IIGI) on circulating concentrations of sRAGE. Samples from eight individuals with type 2 diabetes and eight age-, gender-, and body mass index (BMI)-matched controls, all of whom underwent three differently dosed OGTTs (25 g, 75 g, and 125 g), and three matched IIGIs were utilised (NCT00529048). Serum concentrations of sRAGE were measured over 240 min during each test. For individuals with diabetes, sRAGE area under the curve (AUC0-240min) declined with increasing i.v. glucose dosages (p < 0.0001 for trend) and was lower during IIGI compared to OGTT at the 125 g dosage (p = 0.004). In control subjects, sRAGE AUC0-240min was only lower during IIGI compared to OGTT at the 25 g dose (p = 0.0015). sRAGE AUC0-240min was negatively correlated to AUC0-240min for the incretin hormone glucagon-like peptide -1 (GLP-1) during the 75 g OGTT and matched IIGI, but only in individuals with type 2 diabetes. These data suggest that gastrointestinal factors may play a role in regulating sRAGE concentrations during postprandial glucose excursions, thus warranting further investigation.

• Authors: Amelia K Fotheringham, Jonatan I Bagger, Danielle J Borg, Domenica A McCarthy, Jens J Holst, Tina Vilsbøll, Filip K Knop, Josephine M Forbes
• Journal: Nutrients (Nutrients) Vol. 12 Issue 10 (Sep 24 2020) ISSN: 2072-6643 [Electronic] Switzerland
• PMID: 32987824 (Publication Type: Journal Article)

Chemical References

• Blood Glucose
• Incretins
• Receptor for Advanced Glycation End Products
• Glucagon-Like Peptide 1
• Glucose

Topics

• Administration, Oral
• Aged
• Blood Glucose
• Body Mass Index
• Diabetes Complications (complications)
• Diabetes Mellitus, Type 2 (blood, metabolism)
• Female
• Glucagon-Like Peptide 1 (metabolism)
• Glucose (administration & dosage)
• Glucose Tolerance Test
• Homeostasis
• Humans
• Incretins
• Male
• Middle Aged
• Receptor for Advanced Glycation End Products (metabolism)